Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism

American Journal of Medicine

Volumn 105, Issue 1, 1998, Pages 41-43

  Grady, Deborah ^a   Sawaya, George ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ARTICLE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FRACTURE; HUMAN; LUNG EMBOLISM; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; PULMONARY EMBOLISM; RISK; RISK FACTORS; THROMBOPHLEBITIS; UNITED STATES;

EID: 0032126706     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00136-3     Document Type: Article

References (25)

1. Vessey M., Mant D., Smith A., Yeates D. Oral contraceptives and venous thromboembolism findings in a large prospective study . BMJ. 292:1986;526.
2. Venous thromboembolic disease and combined oral contraceptives results of an international multicentre case-control study . Lancet. 346:1995;1575-1582.
3. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. NEJM. 290:1974;15-19.
4. Petitti D.B., Wingerd J., Pellegrin F., Ramcharan S. Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors. JAMA. 242:1979;1150-1154.
5. Devor M., Barrett-Connor E., Renvall M., et al. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med. 92:1992;275-282.
6. Nachtigall L.E., Nachtigall R.H., Nachtigall R.D., Beckman E.M. Estrogen replacement therapy II a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems . Obstet Gynecol. 54:1979;74-79.
7. Daly E., Vessey M.P., Hawkins M.M., et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 348:1996;977-980.
8. Jick H., Derby L.E., Myers M.W., et al. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet. 348:1996;981-983.
9. Grodstein F., Stampfer M.J., Goldhaber S.Z., et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet. 348:1996;983-987.
10. Gutthann S.P. Hormone replacement therapy and risk of venous thromboembolism population based case-control study . BMJ. 314:1997;796-800.
11. Varas-Lorenzo C., Garcia-Rodríguez L.A., Cattaruzzi C., et al. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism a population-based study in Southern Europe . Am J Epidemiol. 147:1998;387-390.
12. Grady D., Hulley S.B., Furberg C. Venous thromboembolic events associated with hormone replacement therapy. JAMA. 278:1997;477. Letter.
13. Randomized comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. BMJ. 312:1996;473-478.
14. Nabulsi A.A., Folsom A.R., White A., et al. Association of hormone relacement therapy with various cardiovascular risk factors in postmenopausal women. NEJM. 328:1993;1069-1075.
15. Meilahn E.N., Kuller L.H., Matthews K.A., Kiss J.E. Hemostatic factors according to menopausal status and use of hormone replacement therapy. Ann Epidemiol. 2:1992;445-455.
16. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 273:1995;199-208.
17. Manolio T.A., Furberg C.D., Shemanski L., et al. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 88:1993;2163-2171.
18. Koh K.K., Mincemoyer R., Bui M.N., et al. Effects of hormone replacement therapy on fibrinolysis in postmenopausal women. NEJM. 336:1997;683-690.
19. Carter C.J. The natural history and epidemiology of venous thrombosis. Prog Cardiovasc Dis. 36:1994;423-438.
20. Nordstrom M., Lindblad B., Bergqvist D., Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 232:1992;155-160.
21. Prandoni P., Lensing A.W.A., Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 125:1996;1-7.
22. Clagett G.P., Anderson F.A., Heit J., et al. Prevention of venous thromboembolism. Chest. 4:(suppl):1995;312S-334S.
23. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 305:1992;567-574.
24. Quinn D.A., Thompson B.T., Terrin M.L., et al. A prospective investigation of pulmonary embolism in women and men. JAMA. 268:1992;1689-1696.
25. Goldhaber S.Z., Grodstein F., Stampfer M.J., et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 277:1997;642-645.